SC
CELG

SouthState Corp’s Celgene Corp CELG Stock Holding History

SouthState Corp’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,420
Closed -$1.33M – 254
2019
Q3 		$1.33M Sell
13,420
-26,681
-67% -$2.54M 0.17% 110
2019
Q2 		$3.71M Sell
40,101
-500
-1% -$47.5K 0.43% 74
2019
Q1 		$3.83M Buy
40,601
+155
+0.4% +$13.6K 0.39% 76
2018
Q4 		$2.59M Buy
40,446
+11,832
+41% +$873K 0.3% 91
2018
Q3 		$2.56M Buy
28,614
+11,403
+66% +$1.01M 0.26% 101
2018
Q2 		$1.37M Buy
17,211
+823
+5% +$68.3K 0.15% 121
2018
Q1 		$1.46M Buy
16,388
+5,977
+57% +$574K 0.17% 113
2017
Q4 		$1.09M Buy
10,411
+3,648
+54% +$412K 0.12% 143
2017
Q3 		$986 Sell
6,763
-430
-6% -$58.6K 0.11% 133
2017
Q2 		$934K Sell
7,193
-589
-8% -$72.2K 0.12% 135
2017
Q1 		$969K Buy
+7,782
New +$931K 0.13% 137

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

SouthState Corp's CELG Position: Q4 2019 in Review

SouthState Corp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,420 shares — an estimated $1.33M sold.

SouthState Corp first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $3.83M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SouthState Corp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SouthState Corp sold 13,420 Celgene Corp shares in Q4 2019, an estimated $1.33M.
  • SouthState Corp first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • SouthState Corp's Celgene Corp position peaked at $3.83M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SouthState Corp's 13F filing for Q4 2019, filed 5 Feb 2020.